Medincell’s Dr Grace Kim to Participate in Piper Sandler CNS Symposium
Medincell (Euronext Paris: MEDCL), a clinical- and commercial-stage innovation-driven biopharmaceutical company developing and licensing long-acting injectable treatments across multiple therapeutic areas, announced today that Dr Grace Kim, Chief Strategy Officer, U.S. Finance, will take part in the annual Piper Sandler CNS Symposium Thursday, August 13, 2026.
Dr Kim will engage with investors in a fireside discussion led by Piper Sandler analysts at 12:30 p.m. ET virtually.
One-on-one meetings may be scheduled directly with Medincell.
About Medincell
